CLOV - CIK 0001801170
The table below shows CLOVER HEALTH INVESTMENTS, CORP. /DE's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $107.89M | -$16.29M | $25.93M | $79.03M | -$57.04M | -$92.87M |
| Capital expenditure | $854.00K | $185.00K | $445.00K | $251.00K | $158.00K | $99.00K |
| Investing cash flow | -$5.07M | $8.93M | $9.19M | $10.18M | $36.51M | -$257.48M |
| Dividends paid | - | - | - | - | - |
CLOVER HEALTH INVESTMENTS, CORP. /DE reported operating cash flow of -$66.93M for fiscal year 2025. That is down 292.1% from $34.84M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from -$159.88M (FY 2019) to -$66.93M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $0.00 | $18.30M | $0.00 | $2.98M | $5.94M | $0.00 |
| Financing cash flow | -$7.86M | -$31.74M | -$3.36M | -$2.13M | -$5.61M | $662.50M |